Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The investigators noticed that Body Fat Ratio might have great influence on the efficacy of different lipid soluble anesthetics. The objective of this clinical trial was to compare the effect of that Body Fat Ratio on the efficacy of different lipid soluble anesthetics.
The objective of this clinical trial was to compare the effect of that Body Fat Ratio on the efficacy of different lipid soluble anesthetics.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| low body fat percentage | Experimental | body fat percentage less than 30% |
|
| heigh body fat percentage | Experimental | body fat percentage more than 30% |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Sufentanil (R30730, brand name Sufenta) | Drug | sufentanil 1ug/ml |
|
| Measure | Description | Time Frame |
|---|---|---|
| visual analogue pain scores | we evaluate visual analogue pain scores at different time points within 24 hours after surgery | 24hour |
| Measure | Description | Time Frame |
|---|---|---|
| nausea & vomiting | we evaluate nausea & vomiting at different time points within 24 hours after surgery. we ask the patient if she feel nausea or/and occured vomit, if so, 1 time will be recorded in the time point for incidence. | 24hour |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| zhou yan, MD | PKU 1st hospital | Principal Investigator |
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Aug 11, 2020 | |
| Reset | Aug 24, 2020 | |
| Release | Aug 25, 2020 |
Not provided
Not provided
Not provided
Not provided
Not provided
| Sufentanil (R30730, brand name Sufenta) + Morphine | Drug | sufentanil 0.5ug/ml+morphine 0.25mg/ml |
|
| Morphine | Drug | morphine 0. 5mg/ml |
|
| Reset | Sep 15, 2020 |
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Aug 11, 2020 | Aug 24, 2020 | |||
| Aug 25, 2020 | Sep 15, 2020 |
| ID | Term |
|---|---|
| D017409 | Sufentanil |
| D009020 | Morphine |
| ID | Term |
|---|---|
| D005283 | Fentanyl |
| D010880 | Piperidines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
| D009022 | Morphine Derivatives |
| D009019 | Morphinans |
| D053610 | Opiate Alkaloids |
| D000470 | Alkaloids |
| D006572 | Heterocyclic Compounds, Bridged-Ring |
| D006576 | Heterocyclic Compounds, 4 or More Rings |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D010616 | Phenanthrenes |
| D011084 | Polycyclic Aromatic Hydrocarbons |
| D011083 | Polycyclic Compounds |
Not provided
Not provided